Cargando…
Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical Bordetella spp.
Acute pathogens such as Bordetella pertussis can cause severe disease but are ultimately cleared by the immune response. This has led to the accepted paradigm that convalescent immunity is optimal and therefore broadly accepted as the “gold standard” against which vaccine candidates should be compar...
Autores principales: | Gestal, Monica C., Howard, Laura K., Dewan, Kalyan K., Harvill, Eric T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865921/ https://www.ncbi.nlm.nih.gov/pubmed/35196124 http://dx.doi.org/10.1128/msphere.00892-21 |
Ejemplares similares
-
Enhancement of immune response against Bordetella spp. by disrupting immunomodulation
por: Gestal, Monica C., et al.
Publicado: (2019) -
Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae
por: Gestal, Monica C., et al.
Publicado: (2018) -
Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections
por: Gestal, Monica C., et al.
Publicado: (2019) -
Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
por: Soumana, Illiassou Hamidou, et al.
Publicado: (2021) -
Did new transmission cycles in anthropogenic, dense, host populations encourage the emergence and speciation of pathogenic Bordetella?
por: Dewan, Kalyan K., et al.
Publicado: (2019)